Name

IDH2 Gene

isocitrate dehydrogenase 2 (NADP+), mitochondrial

Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]

idh2 Gene Set

From GeneRIF Biological Term Annotations

genes co-occuring with the biological term idh2 in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.

IDH2 Gene Set

From Pathway Commons Protein-Protein Interactions

interacting proteins for IDH2 from the Pathway Commons Protein-Protein Interactions dataset.

IDH2 Gene Set

From LINCS L1000 CMAP CRISPR Knockout Consensus Signatures

genes differentially expressed following the IDH2 gene perturbation from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.

IDH2 Gene Set

From CM4AI KOLF21J CRISPRi Gene Perturbation Atlas

genes differentially expressed following the IDH2 gene perturbation from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas.

IDH2 MUTANT INHIBITOR SH1573 Gene Set

From DGIdb Drug Targets 2026

interacting proteins for the IDH2 MUTANT INHIBITOR SH1573 drug from theDGIdb Drug Targets 2026 dataset.

IDH2 MUTANT INHIBITOR TQB3455 Gene Set

From DGIdb Drug Targets 2026

interacting proteins for the IDH2 MUTANT INHIBITOR TQB3455 drug from theDGIdb Drug Targets 2026 dataset.